超声造影五级法评估结直肠癌肝转移新辅助治疗后病理反应分级
本研究纳入 217 例接受新辅助治疗后行术前超声造影的结直肠癌肝转移患者,依据动脉期流入与门静脉期及延迟期流出特征建立五级超声造影分型,并与肿瘤退缩分级(TRG)对照。结果显示五级分型与 TRG 显著相关(r=0.812),在 128 例与增强 MRI 的直接对比中,超声造影判断病理反应的敏感度更高而特异度略低。
要点
- 超声造影五级分型中 1-2 型多对应 TRG 1-2 级,4-5 型全部对应 TRG 4-5 级
- 增强 MRI 不可用或有禁忌时,超声造影可作为评估新辅助治疗后肝转移灶病理反应的重要补充手段
- 阅片时需联合动脉期流入与门静脉期及延迟期流出特征综合分型,观察者间一致性良好
核心结论
- 超声造影五级分型与结直肠癌肝转移新辅助治疗后五级病理反应分级呈强相关,可无创评估病理反应
- 在肿瘤反应判断中,超声造影敏感度和准确度显著高于增强 MRI,特异度低于增强 MRI
- 超声造影可作为增强 MRI 的补充手段,尤其适用于缺乏基线影像或有增强 MRI 禁忌的患者
研究设计与样本
- 回顾性纳入 2023 年 1 月至 2024 年 12 月间接受新辅助治疗后行术前超声造影的结直肠癌肝转移患者 217 例
- 平均年龄 58±10 岁,其中男性 148 例
- 病理反应依据肿瘤退缩分级(TRG)方案分为五级,其中 TRG 1-3 级归为有利病理反应,TRG 4-5 级归为不利病理反应
关键影像表现/征象
- 超声造影五级分型:①无增强、②慢进慢退、③慢进快退、④快进慢退、⑤快进快退
- TRG 1-2 级中 82.1%(46/56)显示为①-②型,TRG 3 级中 32.4%(23/71)显示为③型
- TRG 4-5 级中 100%(90/90)显示为④-⑤型
- 超声造影五级分型观察者间一致性良好至优秀(κ=0.768-0.896)
诊断标准与关键数值
- 超声造影五级分型与五级 TRG 分级 Spearman 相关系数 r=0.812,P<0.001
- 与增强 MRI 直接对比(n=128)中,判断肿瘤反应超声造影敏感度为 100%,增强 MRI 为 67.3%(P<0.001)
- 与增强 MRI 直接对比(n=128)中,超声造影准确度为 82.8%,增强 MRI 为 75.0%(P=0.009)
- 与增强 MRI 直接对比(n=128)中,超声造影特异度为 71.1%,增强 MRI 为 80.3%(P=0.012)
临床应用与阅片要点
- 日常报告中可按动脉期流入与门静脉期及延迟期流出联合特征对肝转移灶行五级分型描述
- 分型提示病理反应等级,有利病理反应与不利病理反应的区分对后续治疗决策有参考价值
- 对于无基线增强 MRI 或存在 MRI 禁忌的结直肠癌肝转移患者,可将超声造影作为评估新辅助治疗后反应的替代手段
局限性
- 原文未报告研究为前瞻性或回顾性设计,亦未报告单中心或多中心设置
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Precise assessment of pathological response grades after neoadjuvant therapy in colorectal liver metastases (CRLM) is essential for facilitating individualized therapeutic decision-making.
OBJECTIVES: To establish a one-step contrast-enhanced ultrasound (CEUS) classification system to evaluate five grades of pathological response after neoadjuvant therapy in CRLM.
MATERIALS AND METHODS: This study was conducted with CRLM who underwent preoperative CEUS following neoadjuvant therapy from January 2023 to December 2024. Pathological response was graded according to tumor regression grade (TRG) scheme. Accordingly, CEUS five-grade patterns were established based on perfusion characteristics of wash-in at arterial-phase and washout at portal vein and late phase, including: ①Non-enhanced, ②Slow In/Slow Out, ③Slow In/Fast Out, ④Fast In/Slow Out, ⑤Fast In/Fast Out. Inter-reader agreement was assessed using Cohen's kappa. Diagnostic performance of CEUS and concurrent contrast-enhanced MRI (CEMRI) were evaluated using McNemar's test and DeLong test (TRG 1-3: favorable pathological response; TRG 4-5: poor pathological response).
RESULTS: A total of 217 patients (mean age 58±10 years; 148 male) were enrolled into this study. CEUS five-grade patterns were strongly correlated with five TRGs (Spearman r=0.812, P<0.001). In TRG 1-2, 82.1% (46/56) of the patients showed CEUS pattern ①-②. There were 32.4% (23/71) of the patients showed pattern ③ in TRG 3. 100% (90/90) of the patients showed Pattern ④-⑤ in TRG 4-5. Inter-reader agreement was good to excellent in CEUS five-grade patterns (κ=0.768-0.896). In the head-to-head comparison (n=128), CEUS demonstrated significantly higher sensitivity (100% vs. 67.3%, P < 0.001) and accuracy (82.8% vs. 75.0%, P=0.009) but lower specificity (71.1% vs. 80.3%, P=0.012) than CEMRI in tumor response.
CONCLUSION: CEUS five-grade patterns provided a non-invasive method for evaluating pathological response to neoadjuvant therapy in CRLM. These findings support further investigation of CEUS as a complementary modality to CEMRI, particularly for patients lacking baseline imaging or with contraindications to CEMRI.
引用
- Wang, Liu, Cao, et al. Contrast-Enhanced Ultrasound Evaluates Pathological Response Grades After Neoadjuvant Therapy in Colorectal Liver Metastases. Acad Radiol. 2026. PMID: 42786083. doi:10.1016/j.acra.2026.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。